419 related articles for article (PubMed ID: 26787414)
1. Ethosomal Hydrogel of Raloxifene HCl: Statistical Optimization & Ex Vivo Permeability Evaluation Across Microporated Pig Ear Skin.
Thakkar HP; Savsani H; Kumar P
Curr Drug Deliv; 2016; 13(7):1111-1122. PubMed ID: 26787414
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation.
Mahmood S; Mandal UK; Chatterjee B
Int J Pharm; 2018 May; 542(1-2):36-46. PubMed ID: 29501737
[TBL] [Abstract][Full Text] [Related]
3. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application.
Mahmood S; Taher M; Mandal UK
Int J Nanomedicine; 2014; 9():4331-46. PubMed ID: 25246789
[TBL] [Abstract][Full Text] [Related]
4. Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment.
Nagai N; Ogata F; Otake H; Nakazawa Y; Kawasaki N
Int J Nanomedicine; 2018; 13():5215-5229. PubMed ID: 30233182
[TBL] [Abstract][Full Text] [Related]
5. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies.
Fahmy AM; El-Setouhy DA; Ibrahim AB; Habib BA; Tayel SA; Bayoumi NA
Drug Deliv; 2018 Nov; 25(1):12-22. PubMed ID: 29219628
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene encapsulated spanlastic nanogel for the prevention of bone fracture risk via transdermal administration: Pharmacokinetic and efficacy study in animal model.
Ansari MD; Shafi S; Pandit J; Waheed A; Jahan RN; Khan I; Vohora D; Jain S; Aqil M; Sultana Y
Drug Deliv Transl Res; 2024 Jun; 14(6):1635-1647. PubMed ID: 37996726
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate Aspasomes Against Rheumatoid Arthritis: Optimized Hydrogel Loaded Liposomal Formulation with In Vivo Evaluation in Wistar Rats.
Ghosh S; Mukherjee B; Chaudhuri S; Roy T; Mukherjee A; Sengupta S
AAPS PharmSciTech; 2018 Apr; 19(3):1320-1336. PubMed ID: 29340978
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
9. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene.
Alhakamy NA; Fahmy UA; Ahmed OAA
PLoS One; 2019; 14(12):e0226639. PubMed ID: 31881053
[TBL] [Abstract][Full Text] [Related]
11. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
12. Nanoethosomes for transdermal delivery of tropisetron HCl: multi-factorial predictive modeling, characterization, and ex vivo skin permeation.
Abdel Messih HA; Ishak RA; Geneidi AS; Mansour S
Drug Dev Ind Pharm; 2017 Jun; 43(6):958-971. PubMed ID: 28121196
[TBL] [Abstract][Full Text] [Related]
13. Quality by design driven development of resveratrol loaded ethosomal hydrogel for improved dermatological benefits via enhanced skin permeation and retention.
Arora D; Nanda S
Int J Pharm; 2019 Aug; 567():118448. PubMed ID: 31226472
[TBL] [Abstract][Full Text] [Related]
14. Development of an optimized avanafil-loaded invasomal transdermal film: Ex vivo skin permeation and in vivo evaluation.
Ahmed OAA; Badr-Eldin SM
Int J Pharm; 2019 Oct; 570():118657. PubMed ID: 31491483
[TBL] [Abstract][Full Text] [Related]
15. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
16. In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance.
Ahmed OA; Badr-Eldin SM
Int J Nanomedicine; 2018; 13():6325-6335. PubMed ID: 30349253
[TBL] [Abstract][Full Text] [Related]
17. Revitalizing the local anesthetic effect of Mebeverine hydrochloride via encapsulation within ethosomal vesicular system.
Hasan AA; Samir RM; Abu-Zaid SS; Abu Lila AS
Colloids Surf B Biointerfaces; 2020 Oct; 194():111208. PubMed ID: 32590242
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study.
Morsi NM; Aboelwafa AA; Dawoud MHS
J Liposome Res; 2018 Jun; 28(2):137-148. PubMed ID: 28264602
[TBL] [Abstract][Full Text] [Related]
19. Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study.
Shah N; Seth A; Balaraman R; Sailor G; Javia A; Gohil D
Drug Dev Ind Pharm; 2018 Apr; 44(4):687-696. PubMed ID: 29168671
[TBL] [Abstract][Full Text] [Related]
20. Liposomal hydrogel formulation for transdermal delivery of pirfenidone.
Jose A; Mandapalli PK; Venuganti VV
J Liposome Res; 2016; 26(2):139-47. PubMed ID: 26114208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
